ConCon Amendment 19 - Laserfiche WebLink

Home Browse Search

AMENDMENT #19 Exhibit A, Statements of Work Revised as of January 15, 2021 Page 18 of 30 Contract Number CLH18249-19 *For Information Only: Funding is not tied to the revised Standards/Measures listed here. This information may be helpful in discussions of how prog ram activities might contribute to meeting a Standard/Measure. More detail on these and/or other Public Health Accreditation Board (PHAB) Standards/Measures that may apply can be found at: http://www.phaboard.org/wp-content/uploads/PHAB-Standards-and-Measures-Version-1.0.pdf Program Specific Requirements/Narrative Any subcontract/s must be approved by DOH prior to executing the contract/s. Deliverables are to be submitted to the ConCon deliverables mailbox at concondeliverables@doh.wa.gov Special Requirements Federal Funding Accountability and Transparency Act (FFATA) This statement of work is supported by federal funds that require compliance with the Federal Funding Accountability and Transparency Act (FFAT A or the Transparency Act). The purpose of the Transparency Act is to make information available online so the public can see how the federal funds are spent. To comply with this act and be eligible to perform the activities in this statement of work, the LHJ must have a Data Univers al Numbering System (DUNS®) number. Information about the LHJ and this statement of work will be made available on USASpending.gov by DOH as required by P.L. 109-282. Restrictions on Funds (what funds can be used for which activities, not direct payments, etc) Please reference the Code of Federal Regulations: https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=1&SID=58ffddb5363a27f26e9d12ccec462549&ty=HTML&h=L&mc=true&r=PART&n=pt2.1.200#se2.1.200_1439 Allowable Activities - See list of allowable activities below, Appendix 2 from COVID-19 Crisis Response Cooperative Agreement – Components A and B Supplemental Funding, Interim Guidance, March 15, 2020. Costs that are NOT allowable • Facility purchases – May be if prior approval received from the feds and state. Send those requests to Amy.Ferris@doh.wa.gov • Research • Clinical care except as provided for individuals while under state or federal quarantine and isolation orders that are not eligible for payment by another source. • Publicity and propaganda (lobbying): • Other than for normal and recognized executive -legislative relationships, no funds may be used for: o publicity or propaganda purposes, for the preparation, distribution, or use of any material designed to support or defeat the enactment of legislation before any legislative body o the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity design ed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pen ding before any legislative body o See Additional Requirement (AR) 12 for detailed guidance on this prohibition and additional guidance on lobbying for CDC reci pients: https://www.cdc.gov/grants/documents/Anti-Lobbying_Restrictions_for_CDC_Grantees_July_2012.pdf • Funds cannot be used to supplant existing federal funds awarded by other federal sources • Funds cannot be used to match funding on other federal awards. DOH Program Contact Tory Henderson, Contracts & Finance Specialist Department of Health P O Box 47960, Olympia, WA 98504-7960 Office: 360-236-4596 Mobile: 360-789-7262 / tory.henderson@doh.wa.gov